<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04724551</url>
  </required_header>
  <id_info>
    <org_study_id>NLR-IPC 2020-058</org_study_id>
    <nct_id>NCT04724551</nct_id>
  </id_info>
  <brief_title>The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula</brief_title>
  <acronym>NLR</acronym>
  <official_title>The Neutrophil-to-Lymphocyte Ratio at Post-operative Day 3: a Simple Tool to Exclude Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Paoli-Calmettes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Paoli-Calmettes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is still no consensus on whether drain fluid amylase (DFA) level, C-reactive protein&#xD;
      (CRP) level, or complex scores predict clinically relevant postoperative pancreatic fistula&#xD;
      (CR-POPF). The aim of this study is to determine the accuracy of simple biochemical&#xD;
      parameters (leucocytes, neutrophils, lymphocytes, Neutrophil to Lymphocytes Ratio (NLR), at&#xD;
      postoperative days 1 and 3) to exclude the diagnosis of CR-POPF.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      From January 1, 2012 to December 31, 2020, consecutive patients underwent PD performed at&#xD;
      Institut Paoli-Calmettes for various pathologies. Data were entered prospectively into a&#xD;
      clinical database (NCT02871336).&#xD;
&#xD;
      The cohort was split into 3 groups:&#xD;
&#xD;
        -  a training cohort ;&#xD;
&#xD;
        -  an internal validation cohort (Paoli Calmettes institute);&#xD;
&#xD;
        -  an external validation cohort (Rennes Pontchaillou Hospital).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2012</start_date>
  <completion_date type="Actual">February 28, 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of clinically relevant pancreatic fistula</measure>
    <time_frame>at hospital discharge assessed up to 30 days</time_frame>
    <description>Clinically relevant postoperative pancreatic fistula according to the 2016 International Study Group of Pancreatic Surgery definition</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biological markers</measure>
    <time_frame>Postoperative day one and three</time_frame>
    <description>Identification of biological markers to exclude clinically relevant postoperative pancreatic fistula</description>
  </secondary_outcome>
  <enrollment type="Actual">648</enrollment>
  <condition>Pancreas Neoplasm</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pancreatoduodenectomy (PD)</intervention_name>
    <description>A pancreaticogastrostomy or -jejunostomy duct-to-mucosa was achieved according to the surgeon's preference and pancreatic texture.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        3 cohorts, which were as follows: the set of 451 patients was randomly sampled following a&#xD;
        ratio 2:1 into a training (n=301) and a validation (n=150) cohort to respectively determine&#xD;
        and validate the accuracy, best timing, and cut-off for the surrogate markers, then&#xD;
        validated in an external cohort (n=197).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who underwent pancreatoduodenectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Total pancreatectomy&#xD;
&#xD;
          -  Enucleation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Turrini, PD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Paoli-Calmettes- (IPC)</affiliation>
  </overall_official>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2021</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pancreatic fistula</keyword>
  <keyword>Neutrophil-to-Lymphocyte Ratio</keyword>
  <keyword>Pancreatoduodenectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Pancreatic Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

